Rizmoic
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rizmoic, covering 2025-12-10 to 2025-12-10. Get the full timeline:
Most recent: EMA Authorised: Rizmoic (naldemedine tosilate) — Shionogi B.V.
1 regulatory and trial event tracked for Rizmoic, covering 2025-12-10 to 2025-12-10. Get the full timeline:
Most recent: EMA Authorised: Rizmoic (naldemedine tosilate) — Shionogi B.V.